Literature DB >> 33827560

Collaborating to offer HPV vaccinations in jails: results from a pre-implementation study in four states.

Amanda Emerson1, Molly Allison2, Lisa Saldana3, Patricia J Kelly4, Megha Ramaswamy5.   

Abstract

BACKGROUND: Correctional facilities are an underutilized venue for reaching young adults who have not vaccinated for human papillomavirus (HPV). The objective of this study was to identify factors that are associated with jail and local health department (LHD) interest in partnering to offer HPV vaccinations to young adults in jail.
METHODS: Consolidated framework for implementation research (CFIR)-guided surveys were conducted with jail administrators in Iowa, Kansas, Missouri, and Nebraska, September 2017-October 2018. Jail survey data were analyzed using chi square distribution and relative risk regression. Using data from sister surveys conducted with LHD administrators in the same counties (results previously reported), we identified characteristics of counties in which both the jail and LHD indicated interest in collaborating to offer HPV vaccinations in the jail.
RESULTS: Jail survey response was 192/347 (55.3%). Surveys with LHDs yielded 237/344 (68.9%) responses. Eleven communities were identified where both the jail and LHD expressed interest. Only "any vaccines provided in jail" predicted shared interest (RR: 5.36; CI: 2.52-11.40; p < .01). For jail administrators, offering other vaccines was 3 times (CI:1.49-6.01; p < .01) and employing a nurse 1.65 times more likely (CI: 1.20-2.28; p < .01) to predict interest in collaborating to offer HPV vaccination. Open-ended responses indicated that managing linkages and stakeholder investment were areas of emphasis where collaborations to provide vaccinations in the jails had been previously implemented.
CONCLUSIONS: Interest in jail-LHD partnerships to provide HPV vaccinations in jails exists in the Midwest but will require building-out existing programs and linkages and identifying and strengthening shared values, goals, and benefits at all levels.

Entities:  

Keywords:  Health departments; Human papillomavirus; Interagency collaboration; Prisoner populations; Vaccination

Year:  2021        PMID: 33827560     DOI: 10.1186/s12913-021-06315-5

Source DB:  PubMed          Journal:  BMC Health Serv Res        ISSN: 1472-6963            Impact factor:   2.655


  17 in total

Review 1.  Overcoming the barriers to HPV vaccination in high-risk populations in the US.

Authors:  Levi S Downs; Isabel Scarinci; Mark H Einstein; Yvonne Collins; Lisa Flowers
Journal:  Gynecol Oncol       Date:  2010-03-29       Impact factor: 5.482

2.  Prevalence of chronic medical conditions among jail and prison inmates in the USA compared with the general population.

Authors:  I A Binswanger; P M Krueger; J F Steiner
Journal:  J Epidemiol Community Health       Date:  2009-07-30       Impact factor: 3.710

3.  Chronic medical conditions in U.S. adults with incarceration history.

Authors:  Tomoko Udo
Journal:  Health Psychol       Date:  2019-03       Impact factor: 4.267

Review 4.  Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study.

Authors:  Mojtaba Vaismoradi; Hannele Turunen; Terese Bondas
Journal:  Nurs Health Sci       Date:  2013-03-11       Impact factor: 1.857

5.  Immunizations and jails.

Authors:  Megha Ramaswamy
Journal:  Public Health Nurs       Date:  2017-09       Impact factor: 1.462

6.  Human Papillomavirus Vaccine Knowledge and Intention Among Adult Inmates in Kansas, 2016-2017.

Authors:  Molly Allison; Brynne Musser; Catherine Satterwhite; Kevin Ault; Patricia Kelly; Megha Ramaswamy
Journal:  Am J Public Health       Date:  2018-06-21       Impact factor: 9.308

7.  Local Health Department Interest in Implementation of a Jail-Based Human Papillomavirus Vaccination Program in Kansas, Iowa, Missouri, and Nebraska.

Authors:  Megha Ramaswamy; Molly Allison; Brynne Musser; Catherine Satterwhite; Robert Armstrong; Patricia J Kelly
Journal:  J Public Health Manag Pract       Date:  2020 Mar/Apr

8.  Racial and ethnic disparities in human papillomavirus-associated cancer burden with first-generation and second-generation human papillomavirus vaccines.

Authors:  Emily A Burger; Kyueun Lee; Mona Saraiya; Trevor D Thompson; Harrell W Chesson; Lauri E Markowitz; Jane J Kim
Journal:  Cancer       Date:  2016-04-28       Impact factor: 6.860

Review 9.  Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.

Authors:  Catherine Lindsey Satterwhite; Elizabeth Torrone; Elissa Meites; Eileen F Dunne; Reena Mahajan; M Cheryl Bañez Ocfemia; John Su; Fujie Xu; Hillard Weinstock
Journal:  Sex Transm Dis       Date:  2013-03       Impact factor: 2.830

10.  Barriers and facilitators of implementing a collaborative HPV vaccine program in an incarcerated population: A case study.

Authors:  Amanda Emerson; Molly Allison; Patricia J Kelly; Megha Ramaswamy
Journal:  Vaccine       Date:  2020-02-08       Impact factor: 3.641

View more
  1 in total

1.  Legislatively mandated implementation of medications for opioid use disorders in jails: A qualitative study of clinical, correctional, and jail administrator perspectives.

Authors:  Ekaterina Pivovarova; Elizabeth A Evans; Thomas J Stopka; Claudia Santelices; Warren J Ferguson; Peter D Friedmann
Journal:  Drug Alcohol Depend       Date:  2022-03-07       Impact factor: 4.852

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.